{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:08:34Z","timestamp":1792112914475,"version":"4.4.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T00:00:00Z","timestamp":1394841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11126-014-9291-9","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T05:42:49Z","timestamp":1395121369000},"page":"345-348","source":"Crossref","is-referenced-by-count":11,"title":["Rechallenging Clozapine After Neuroleptic Malignant Syndrome"],"prefix":"10.1007","volume":"85","author":[{"given":"Emaya","family":"Anbalagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muaid","family":"Ithman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,15]]},"reference":[{"issue":"4","key":"9291_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000119344","volume":"35","author":"M Amore","year":"1997","unstructured":"Amore M, Zazzeri N, Berardi D: Atypical neuroleptic malignant syndrome associated with Clozapine treatment. Neuropsychobiology 35(4):197\u2013199, 1997","journal-title":"Neuropsychobiology."},{"issue":"2\u20133","key":"9291_CR2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","volume":"134","author":"P Manu","year":"2012","unstructured":"Manu P, Sarpal D, Muir O, Kane JM, Correll CU: When can patients with potentially life-threatening adverse effects be rechallenged with Clozapine? A systematic review of the published literature. Schizophrenia Research 134(2\u20133):180\u2013186, 2012. doi: 10.1016\/j.schres.2011.10.014","journal-title":"Schizophrenia Research"},{"issue":"4","key":"9291_CR3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00005053-198804000-00007","volume":"176","author":"VL Susman","year":"1988","unstructured":"Susman VL, Addonizio G: Recurrence of neuroleptic malignant syndrome. The Journal of Nervous and Mental Disease 176(4):234\u2013241, 1988","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"8","key":"9291_CR4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00005053-198608000-00010","volume":"174","author":"HG Pope Jr","year":"1986","unstructured":"Pope HG, Jr., Cole JO, Choras PT, Fulwiler CE: Apparent neuroleptic malignant syndrome with Clozapine and lithium. The Journal of Nervous and Mental Disease 174(8):493\u2013495, 1986","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"6","key":"9291_CR5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0006-3223(90)90485-K","volume":"28","author":"M Halman","year":"1990","unstructured":"Halman M, Goldbloom DS: Fluoxetine and neuroleptic malignant syndrome. Biological Psychiatry 28(6):518\u2013251, 1990","journal-title":"Biological Psychiatry."},{"issue":"3","key":"9291_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00048679409075873","volume":"28","author":"K Wilhelm","year":"1994","unstructured":"Wilhelm K, Curtis J, Birkett V, Kenney-Herbert J: The clinical significance of serial creatine phosphokinase estimations in acute ward admissions. Australian and New Zealand Journal of Psychiatry 28(3):453\u2013457, 1994","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"2","key":"9291_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10401239509149033","volume":"7","author":"G Tsai","year":"1995","unstructured":"Tsai G, Crisostomo G, Rosenblatt ML, Stern TA: Neuroleptic malignant syndrome associated with clozapine treatment. Annals of Clinical Psychiatry 7(2):91\u201395, 1995","journal-title":"Annals of Clinical Psychiatry"},{"issue":"8","key":"9291_CR8","first-page":"522","volume":"24","author":"TL Huang","year":"2001","unstructured":"Huang TL: Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Medical Journal 24(8):522\u2013525, 2001","journal-title":"Chang Gung Medical Journal"},{"issue":"3","key":"9291_CR9","first-page":"102","volume":"52","author":"ES Anderson","year":"1991","unstructured":"Anderson ES, Powers PS: Neuroleptic malignant syndrome associated with clozapine use. Journal of Clinical Psychiatry 52(3):102\u2013104, 1991","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"9291_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004714-199204000-00016","volume":"12","author":"MG Goates","year":"1992","unstructured":"Goates MG, Escobar JI: An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapinetherapy: report of a case and results of a clozapine rechallenge. Journal of Clinical Psychopharmacology 12(2):139\u2013140, 1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"9291_CR11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3109\/00048679609062668","volume":"30","author":"R Chatterton","year":"1996","unstructured":"Chatterton R, Cardy S, Schramm TM: Neuroleptic malignant syndrome and clozapine monotherapy. Australian and New Zealand Journal of Psychiatry 30(5):692\u2013693, 1996","journal-title":"Australian and New Zealand Journal of Psychiatry"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-014-9291-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11126-014-9291-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-014-9291-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:27:02Z","timestamp":1559374022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11126-014-9291-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,15]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9291"],"URL":"https:\/\/doi.org\/10.1007\/s11126-014-9291-9","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,15]]}}}